Degner J

No ORCID on file · 1 paper in corpus
article 2018
Clinical pharmacokinetics ·doi:10.1007/s40262-018-0629-6

IntroductionElagolix is a novel, orally active, non-peptide, competitive gonadotropin-releasing hormone (GnRH) receptor antagonist in development for the management of endometriosis with associated pain and heavy menstrual bleeding due to u…